Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

News

Long-term ADHD Med Use May Hike CVD Risk
News
Long-term ADHD Med Use May Hike CVD Risk
01/02/2024
Long-term exposure to medications for attention-deficit/hyperactivity disorder (ADHD) was associated with an increased risk of cardiovascular disease (CVD) in a case-control study published in JAMA Psychiatry. 
Long-term exposure to medications for attention-deficit/hyperactivity disorder (ADHD) was associated with an increased risk of cardiovascular disease (CVD) in a case-control study published in JAMA Psychiatry. 
Long-term exposure to...
01/02/2024
Psych Congress Network

Advertisement

News
Perseverative Behaviors Warrant Attention in Patients With Huntington Disease
12/28/2023
Separate reporting of obsessive-compulsive behaviors and perseverative behaviors in patients with Huntington disease is uncommon and may allow clinically important behaviors to go unnoticed, according to a review article published in...
Separate reporting of obsessive-compulsive behaviors and perseverative behaviors in patients with Huntington disease is uncommon and may allow clinically important behaviors to go unnoticed, according to a review article published in...
Separate reporting of...
12/28/2023
Neurology
Deep Transcranial Magnetic Stimulation for OCD Likely to Ease Depressive Symptoms
News
Deep Transcranial Magnetic Stimulation for OCD Likely to Ease Depressive Symptoms
12/28/2023
Patients who received deep transcranial magnetic stimulation (dTMS) for OCD showed a significant improvement in both OCD and depressive symptoms, according to a study published in the Journal of Affective Disorders.
Patients who received deep transcranial magnetic stimulation (dTMS) for OCD showed a significant improvement in both OCD and depressive symptoms, according to a study published in the Journal of Affective Disorders.
Patients who received deep...
12/28/2023
Psych Congress Network
News
For Treatment-Resistant Depression, Ketamine and ECT Offer Similar Effectiveness
12/24/2023
Seemingly contradictory findings from recent studies comparing intravenous (IV) ketamine with electroconvulsive therapy (ECT) in outpatients with treatment-resistant depression may have practicing clinicians feeling unsure about which...
Seemingly contradictory findings from recent studies comparing intravenous (IV) ketamine with electroconvulsive therapy (ECT) in outpatients with treatment-resistant depression may have practicing clinicians feeling unsure about which...
Seemingly contradictory findings...
12/24/2023
Psych Congress Network

Advertisement

Psychiatry Family
News
Broader Psychopathology Comorbidity May Fuel Transmission of Conditions to Offspring
12/20/2023
The intergenerational transmission of psychiatric conditions appears to be mostly attributable to broader psychopathology comorbidity than specific conditions, suggest study results.
The intergenerational transmission of psychiatric conditions appears to be mostly attributable to broader psychopathology comorbidity than specific conditions, suggest study results.
The intergenerational...
12/20/2023
Psych Congress Network
plaque
News
Day 1: Late-Breaking Updates From the National Academy of Sciences Conference on Adult ADHD
12/13/2023
Dr Greg Mattingly shares exclusive insights from the historic meeting addressing the Adult ADHD crisis that you do not want to miss.
Dr Greg Mattingly shares exclusive insights from the historic meeting addressing the Adult ADHD crisis that you do not want to miss.
Dr Greg Mattingly shares...
12/13/2023
Psych Congress Network
News
MAPS PBC Submits New Drug Application for MDMA-Assisted Therapy for PTSD
12/12/2023
MAPS Public Benefit Corporation’s new drug application to the US Food and Drug Administration for the use of MDMA in combination with psychotherapy to treat post-traumatic stress disorder is the first filing to the FDA for any...
MAPS Public Benefit Corporation’s new drug application to the US Food and Drug Administration for the use of MDMA in combination with psychotherapy to treat post-traumatic stress disorder is the first filing to the FDA for any...
MAPS Public Benefit...
12/12/2023
Psych Congress Network

Advertisement

Female Soldier or Veteran
News
Pharmacotherapy Suboptimal After Schizophrenia Diagnosis in VHA System
12/12/2023
Study indicates deficiencies in pharmacotherapy practices following schizophrenia diagnosis and underscores the substantial impact of the condition on veterans' hospitalization rates, health care resource utilization (HRU), and associated...
Study indicates deficiencies in pharmacotherapy practices following schizophrenia diagnosis and underscores the substantial impact of the condition on veterans' hospitalization rates, health care resource utilization (HRU), and associated...
Study indicates deficiencies in...
12/12/2023
Psych Congress Network
News
Use of Psilocbyin in Bipolar II Treatment Clinical Trial Produces Strong Results
12/12/2023
In a recent trial conducted by Sheppard Pratt researchers, 80% of participants with treatment-resistant bipolar II met the criteria for remission 12 weeks after treatment that included psilocybin and therapy.
In a recent trial conducted by Sheppard Pratt researchers, 80% of participants with treatment-resistant bipolar II met the criteria for remission 12 weeks after treatment that included psilocybin and therapy.
In a recent trial conducted by...
12/12/2023
Psych Congress Network
News
In MS, Patients With Central Neuropathic Pain Carry Highest Emotional Burden
12/11/2023
Emotional burden and pain severity were greater in patients with multiple sclerosis (MS) who had central neuropathic pain than those who had musculoskeletal pain.
Emotional burden and pain severity were greater in patients with multiple sclerosis (MS) who had central neuropathic pain than those who had musculoskeletal pain.
Emotional burden and pain...
12/11/2023
Neurology

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

Advertisement

Advertisement

Sign Up

Psych Congress Network Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use